Dubawa
Labs na Isomorphic shine Alphabet/DeepMind spinout yana juya ci gaban AlphaFold zuwa injin ƙirar magunguna na farko na AI. Yana da mahimmanci saboda yana da niyyar yin hasashen ba kawai sifofin furotin ba amma yadda kwayoyin ke ɗaure, mai yuwuwar sake fasalin yadda ake gano magunguna.
Ganowar Drug Labs Isomorphic an fi fahimta a cikin mahallin dabarun, samun damar samfuri, yanke shawara na dandamali, da haɗin gwiwar yanayin muhalli.
Zurfafa nutsewa
An kafa shi a cikin 2021 kuma Demis Hassabis ya jagoranta, Labs na Isomorphic ya girma kai tsaye daga DeepMind's AlphaFold, wanda ya warware matsalar nada furotin na shekaru da yawa ta hanyar tsinkayar tsarin 3D daga jerin amino acid. Ƙididdigar Isomorphic ita ce ana iya ɗaukar ilmin halitta azaman tsarin sarrafa bayanai, don haka AI na iya ƙirƙira ma'amalar kwayoyin daidai isa don tsara magunguna da hankali maimakon ta gwaji da kuskure. A cikin 2024 ƙungiyar ta taimaka sakin AlphaFold 3, wanda ke yin hasashen tsarin sunadarai tare da DNA, RNA, ligands da sauran ƙwayoyin cuta - masu mahimmanci don fahimtar ɗaurin ƙwayoyi. Isomorphic ya sanya hannu kan yarjejeniyoyin da suka kai biliyoyin daloli tare da Eli Lilly da Novartis, kuma a cikin 2025 ya tara dala miliyan 600 a cikin kudade na waje don ciyar da nasa shirye-shiryen magunguna na ciki zuwa asibitin.
Fahimtar Fasaha
AlphaFold 3 ya maye gurbin tsarin tsarin AlphaFold 2 tare da janareta na tushen yadawa: yana farawa daga daidaitawar atomic mai surutu kuma yana musanta su a cikin tsari na 3D mai ma'ana, wanda aka tsara akan zurfin wakilcin kwayoyin da ke ciki. Wannan yana ƙyale samfurin guda ɗaya ya sarrafa sunadaran, acid nucleic, ions da ƙananan ƙwayoyin ƙwayoyin cuta a cikin hadaddun guda ɗaya, yana tsinkaya yadda mahaɗin ɗan takara ya shiga cikin aljihun ɗaurin manufa - tambaya ta tsakiya a ƙirar ƙirar magunguna.
Jagorar Binciken Labs na Isomorphic Drug
Labs na Isomorphic shine Alphabet/DeepMind spinout yana juya ci gaban AlphaFold zuwa injin ƙirar magunguna na farko na AI. Yana da mahimmanci saboda yana da niyyar yin hasashen ba kawai sifofin furotin ba amma yadda kwayoyin ke ɗaure, mai yuwuwar sake fasalin yadda ake gano magunguna. Ganowar Drug Labs Isomorphic an fi fahimta a cikin mahallin dabarun, samun damar samfuri, yanke shawara na dandamali, da haɗin gwiwar yanayin muhalli. Don gina zurfin fahimta, bi Isomorphic Labs Drug Discovery azaman samfurin aiki, ba fasali ɗaya ba: ayyana sakamakon da ake so, fayyace zato, da raba abin da tsarin zai iya dogara da abin da har yanzu yana buƙatar yanke hukunci na ƙwararru.
A aikace, ƙungiyoyi masu ƙarfi da ke amfani da Binciken Magunguna na Isomorphic Labs suna kimanta dabarun mai siyarwa, amincin taswirar hanya, da haɗarin kulle-kulle kafin aikatawa. Suna rubuta ƙayyadaddun ƙa'idodin nasara, gwaji akan bayanan gaskiya da gudanawar aiki, da jujjuyawar bisa ga tsarin gazawar da aka lura maimakon cin nasara na lokaci ɗaya. Wannan shine inda fahimtar ka'idar ta juya zuwa iyawa mai dorewa a cikin samfura, manufofi, da ayyuka.
Taswirorin hanyoyin tallace-tallace suna yin tasiri ga abubuwan da ƙungiyar ku za ta iya ginawa na gaba. A lokaci guda, sanarwar ƙaddamarwa na iya wuce kwanciyar hankali a cikin ayyukan samarwa na gaske. Hanyar da ta fi dacewa ita ce haɗa saurin gwaji tare da horon gudanarwa: gudanar da matukin jirgi, kama shaida, buga rajistan ayyukan yanke shawara, da ci gaba da sabunta abubuwan tsaro kamar yadda halayen ƙira, tsammanin mai amfani, da buƙatun tsari ke tasowa.
Dabarun Tasiri
Taswirorin hanyoyin tallace-tallace suna yin tasiri ga abubuwan da ƙungiyar ku za ta iya ginawa na gaba.
Taswirorin hanyoyin tallace-tallace suna yin tasiri ga abubuwan da ƙungiyar ku za ta iya ginawa na gaba. A cikin ƙawance masu inganci, ana fassara wannan zuwa ƙa'idodin aiki waɗanda za a iya aunawa, iyakokin ikon mallaka, da kuma bita-da-kullin bita don ƙungiyoyi su iya haɓaka kwarin gwiwa a maimakon ɓata shakku.
Sharuɗɗan kasuwanci da zaɓuɓɓukan turawa suna shafar farashi na dogon lokaci da haɗari.
Sharuɗɗan kasuwanci da zaɓuɓɓukan turawa suna shafar farashi na dogon lokaci da haɗari. A cikin ƙawance masu inganci, ana fassara wannan zuwa ƙa'idodin aiki waɗanda za a iya aunawa, iyakokin ikon mallaka, da kuma bita-da-kullin bita don ƙungiyoyi su iya haɓaka kwarin gwiwa a maimakon ɓata shakku.
Ƙwararrun kamfani suna siffanta ɓangarorin samfur, yanayin aminci, da buɗewa.
Ƙwararrun kamfani suna siffanta ɓangarorin samfur, yanayin aminci, da buɗewa. A cikin ƙawance masu inganci, ana fassara wannan zuwa ƙa'idodin aiki waɗanda za a iya aunawa, iyakokin ikon mallaka, da kuma bita-da-kullin bita don ƙungiyoyi su iya haɓaka kwarin gwiwa a maimakon ɓata shakku.
Aiwatar da Gaskiyar Duniya
Yin amfani da AlphaFold 3 don yin ƙirar yadda ɗan takara ƙananan ƙwayoyin cuta ke ɗaure a cikin aljihun furotin da ke da manufa kafin kowane haɗin lab.
Haɗin kai tare da Eli Lilly da Novartis don ƙirƙira ƙananan ƙwayoyin ƙwayoyin ƙwayoyin cuta a cikin wuraren cututtuka da yawa.
Hasashen furotin-DNA da rukunin protein-RNA don nazarin makasudin da tsoffin kayan aikin ba za su iya wakilta ba.
Gabatar da waɗanne mahaɗan sinadarai don haɗawa da gwadawa, rage ɓarnawar zagayowar rigar-lab.
Hanyoyin Aiwatarwa
Isomorphic Labs Gano Drug a aikace
Yin amfani da AlphaFold 3 don yin ƙirar yadda ɗan takara ƙananan ƙwayoyin cuta ke ɗaure a cikin aljihun furotin da ke da manufa kafin kowane haɗin lab.
Yin amfani da AlphaFold 3 don yin ƙirar yadda ɗan takara ƙananan ƙwayoyin cuta ke ɗaure a cikin aljihun furotin da ke da manufa kafin kowane haɗin labungiyoyi yawanci suna samun sakamako mafi kyau lokacin da suka ayyana ma'auni masu inganci a gaba, kiyaye hanyar haɓakar ɗan adam don shari'o'in gefe, da bin diddigin nasarorin samarwa da ƙimar kuskure akan lokaci.
Isomorphic Labs Gano Drug a aikace
Haɗin kai tare da Eli Lilly da Novartis don ƙirƙira ƙananan ƙwayoyin ƙwayoyin ƙwayoyin cuta a cikin wuraren cututtuka da yawa.
Haɗin kai tare da Eli Lilly da Novartis don ƙirƙira litattafan ƙananan ƙwayoyin ƙwayoyin cuta a cikin wuraren cututtuka da yawa Ƙungiyoyi yawanci suna samun sakamako mafi kyau lokacin da suka ayyana ƙofofin inganci a gaba, kiyaye hanyar haɓakar ɗan adam don shari'o'i, da bin diddigin nasarorin samarwa da ƙimar kuskure a kan lokaci.
Isomorphic Labs Gano Drug a aikace
Hasashen furotin-DNA da rukunin protein-RNA don nazarin makasudin da tsoffin kayan aikin ba za su iya wakilta ba.
Hasashen furotin-DNA da rukunin furotin-RNA don nazarin maƙasudin waɗanda tsoffin kayan aikin ba za su iya wakiltar ƙungiyoyi yawanci suna samun sakamako mafi kyau lokacin da suka ayyana ƙima masu inganci a gaba, kiyaye hanyar haɓakar ɗan adam don shari'o'in gefe, da bin duk nasarorin samarwa da ƙimar kuskure akan lokaci.
Isomorphic Labs Gano Drug a aikace
Gabatar da waɗanne mahaɗan sinadarai don haɗawa da gwadawa, rage ɓarnawar zagayowar rigar-lab.
Gabatar da waɗanne mahaɗan sinadarai don haɗawa da gwadawa, rage ɓarnawar keɓaɓɓun kekuna-lab Ƙungiyoyi yawanci suna samun sakamako mafi kyau lokacin da suka ayyana ƙofofin inganci a gaba, kiyaye hanyar haɓakar ɗan adam don shari'o'i, da bin duk nasarorin samarwa da farashi na kuskure akan lokaci.
Hatsari & Tsare-tsare
Sanarwar ƙaddamarwa na iya ƙetare kwanciyar hankali a cikin ayyukan samarwa na gaske.
Farashin API ko sauye-sauyen manufofi na iya karya zato cikin dare.
Dogaro mai siyarwa guda ɗaya yana ƙara kulle-kulle da farashin ƙaura.
Taswirar Hanya
Kimanta masu samarwa ta amfani da ayyukan ku da saitin bayanai.
Kimanta masu samarwa ta amfani da ayyukan ku da saitin bayanai. Ɗauki kowane mataki azaman ƙofar shaida: idan ba a cika sharuɗɗa ba, dakatar da fitar, rufe tazarar, sannan kawai faɗaɗa amfani.
Yi bitar sirri, tsaro, da sharuɗɗan doka kafin haɗin kai.
Yi bitar sirri, tsaro, da sharuɗɗan doka kafin haɗin kai. Ɗauki kowane mataki azaman ƙofar shaida: idan ba a cika sharuɗɗa ba, dakatar da fitar, rufe tazarar, sannan kawai faɗaɗa amfani.
Kula da tsarin koma baya a cikin samfura ko masu siyarwa.
Kula da tsarin koma baya a cikin samfura ko masu siyarwa. Ɗauki kowane mataki azaman ƙofar shaida: idan ba a cika sharuɗɗa ba, dakatar da fitar, rufe tazarar, sannan kawai faɗaɗa amfani.
Saka idanu bayanin kula don haka canje-canjen taswirar hanya kada suyi mamakin ƙungiyoyi.
Saka idanu bayanin kula don haka canje-canjen taswirar hanya kada suyi mamakin ƙungiyoyi. Ɗauki kowane mataki azaman ƙofar shaida: idan ba a cika sharuɗɗa ba, dakatar da fitar, rufe tazarar, sannan kawai faɗaɗa amfani.